ARX homeodomain mutations abolish DNA binding and lead to a loss of transcriptional repression
Open Access
- 21 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (7) , 1639-1647
Abstract
Mutations in the Aristaless-related homeobox (ARX) gene are one of the most frequent causes of X-linked intellectual disability (ID). Several missense mutations, clustered in the paired-type homeodomain of ARX, have been identified. These mutations lead to a range of phenotypes from X-linked lissencephaly with abnormal genitalia to seizure disorders without brain malformations including X-linked infantile spasms with ID (ISSX-ID) and X-linked myoclonic epilepsy with spasticity and ID (XMESID). The effect of these mutations on the DNA-binding and transcriptional activity has been evaluated. Luciferase reporter assays showed altered repression activity of ARX by all mutations, causing brain malformations and ISSX-ID phenotypes, but not by the P353L mutation implicated in a milder phenotype of XMESID. Similarly, transient overexpression of wild-type ARX repressed endogenous expression of known ARX targets, LMO1 and SHOX2, when measured by real-time quantitative polymerase chain reaction. Overall, the molecular consequence of missense mutations correlated well with the severity of the clinical phenotype. In all mutations tested, except P353L, the DNA binding was abolished. Electrophoretic mobility shift assay results were validated using chromatin immunoprecipitation following overexpression of normal and selected missense mutations. Unlike wild-type ARX and clinically less severe mutations, the mutations leading to severe clinical phenotypes were not able to specifically bind to DNA upstream of known, endogenous ARX-regulated genes, LMO1 and SHOX2. In conclusion, the missense mutations in the ARX homeodomain represent loss-of-function mutations, which lead to a reduced or complete loss of DNA binding and as a consequence, a loss of transcriptional repression.Keywords
This publication has 31 references indexed in Scilit:
- ARX spectrum disorders: making inroads into the molecular pathologyHuman Mutation, 2010
- Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell divisionPathoGenetics, 2010
- The genetic landscape of intellectual disability arising from chromosome XTrends in Genetics, 2009
- Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous femalesBrain, 2009
- Central and Gonadal Hypogonadism in X-Linked LissencephalyJournal of Pediatric Endocrinology and Metabolism, 2006
- Mutations of ARX are associated with striking pleiotropy and consistent genotype–phenotype correlationHuman Mutation, 2004
- Leptin Levels Increase during Flutamide Therapy in Women with Polycystic Ovary SyndromeHormone Research in Paediatrics, 2003
- Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humansNature Genetics, 2002
- Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsyNature Genetics, 2002
- New X‐linked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosumAmerican Journal of Medical Genetics, 1992